Differential Regulation of Estrogen-Inducible Proteolysis and Transcription by the Estrogen Receptor α N Terminus

REFERENCES

• Alarid, E. T., N. Bakopoulos, and N. Solodin. 1999. Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation. Mol. Endocrinol. 13:1522–1534.
   PubMed Web of Science ®Google Scholar
• Alarid, E. T., M. T. Preisler-Mashek, and N. M. Solodin. 2003. Thyroid hormone is an inhibitor of estrogen-induced degradation of estrogen receptor-α protein: estrogen dependent proteolysis is not essential for receptor transactivation function in the pituitary. Endocrinology 144:3469–3476.
   PubMedGoogle Scholar
• Ali, S., D. Metzger, J.-M. Bornert, and P. Chambon. 1993. Modulation of transcriptional activation by ligand dependent phosphorylation of the human oestrogen receptor A/B region. EMBO J. 12:1153–1160.
   PubMed Web of Science ®Google Scholar
• Borras, M., L. Hardy, F. Lempereur, A. H. El Khissiin, N. Legros, R. Gol-Winkler, and G. Leclercq. 1994. Estradiol-induced down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression. J. Steroid Biochem. Mol. Biol. 48:325–336.
   PubMedGoogle Scholar
• Brown, A. M. C., J.-M. Jeltsch, M. Roberts, and P. Chambon. 1984. Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line, MCF-7. Proc. Natl. Acad. Sci. USA 81:6344–6348.
   PubMed Web of Science ®Google Scholar
• Brzozowski, A. M., A. C. W. Pike, Z. Dauter, R. E. Hubbard, T. Bonn, O. Engström, L. Öhman, G. L. Greene, J.-Å. Gustafsson, and M. Carlquist. 1997. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389:753–758.
   PubMed Web of Science ®Google Scholar
• Campbell, R. A., P. Bhat-Nakshatri, N. M. Patel, D. Constantinidou, S. Ali, and H. Nakshatri. 2001. Phophatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor α. J. Biol. Chem. 276:9817–9824.
   PubMed Web of Science ®Google Scholar
• Castano, E., D. P. Vorojeikina, and A. C. Notides. 1997. Phosphorylation of serine-167 on the human oestrogen receptor is important for oestrogen response element binding and transcriptional activation. Biochem. J. 326:149–157.
   PubMedGoogle Scholar
• Chen, D., T. Riedl, E. Washbrook, P. E. Pace, R. C. Coombes, J.-M. Egly, and S. Ali. 2000. Activation of estrogen receptor α by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of cdk7. Mol. Cell 6:127–137.
   PubMed Web of Science ®Google Scholar
• Conaway, R. C., C. S. Brower, and J. W. Conaway. 2002. Emerging roles of ubiquitin in transcription regulation. Science 296:1254–1258.
   PubMed Web of Science ®Google Scholar
• Dace, A., L. Zhao, K. S. Park, T. Furuno, N. Takamura, M. Nakanishi, B. L. West, J. A. Hanover, and S. Cheng. 2000. Hormone binding induce rapid proteasome-mediated degradation of thyroid hormone receptors. Proc. Natl. Acad. Sci. USA 97:8985–8990.
   PubMed Web of Science ®Google Scholar
• Dutertre, M., and C. L. Smith. 2003. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-α: regulation by phosphorylation sites in the A/B region depends on other receptor domains. Mol. Endocrinol. 17:1296–1314.
   PubMedGoogle Scholar
• El Khissiin, A., and G. Leclercq. 1999. Implication of proteasome in estrogen receptor degradation. FEBS Lett. 448:160–166.
   PubMed Web of Science ®Google Scholar
• El Khissin, A., A. Cleeren, M. Borras, and G. LeClercq. 1997. Protein synthesis is not implicated in the ligand-dependent activation of estrogen receptor in MCF-7 cells. J. Steroid Biochem. Mol. Biol. 62:269–276.
   PubMedGoogle Scholar
• Fan, M., H. Nakshatri, and K. P. Nephew. 2004. Inhibiting proteasomal proteolysis sustains estrogen receptor-α activation. Mol. Endocrinol. 18:2603–2615. (First published 29 July 2004; doi:10.1210/me.2004-0164.)
   PubMedGoogle Scholar
• Ferdous, A., F. Gonzalez, L. Sun, T. Kodadek, and S. A. Johnston. 2001. The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II. Mol. Cell 7:981–991.
   PubMed Web of Science ®Google Scholar
• Ferdous, A., T. Kodadek, and S. A. Johnston. 2002. A nonproteolytic function of the 19S regulatory subunit of the 26S proteasome is required for efficient activated transcription by human RNA polymerase II. Biochemistry 41:12798–12805.
   PubMed Web of Science ®Google Scholar
• Flouriot, G., H. Brand, S. Denger, R. Metivier, M. Kos, G. Reid, V. Sonntag-Buck, and F. Gannon. 2000. Identification of a new isoform of the human estrogen receptor-alpha (hER-α) that is encoded by distinct transcripts and that is able to repress hER-α activation function 1. EMBO J. 19:4688–4700.
   PubMed Web of Science ®Google Scholar
• Hauser, S., G. Adelmant, P. Sarraf, H. M. Wright, E. Mueller, and B. M. Spiegelman. 2000. Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation. J. Biol. Chem. 275:18527–18533.
   PubMed Web of Science ®Google Scholar
• Joel, P. B., J. Smith, T. W. Sturgill, T. L. Fisher, J. Blenis, and D. A. Lannagin. 1998. pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167. Mol. Cell. Biol. 18:1978–1984.
   PubMed Web of Science ®Google Scholar
• Kang, Z., A. Pirskanen, O. A. Janne, and J. J. Palvimo. 2002. Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex. J. Biol. Chem. 277:48366–48371.
   PubMed Web of Science ®Google Scholar
• Kato, S., H. Endoh, Y. Masuhiro, T. Kitamoto, S. Uchiyama, H. Sasaki, S. Masushige, Y. Gotoh, E. Nishida, H. Kawashima, D. Metzger, and P. Chambon. 1995. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491–1494.
   PubMed Web of Science ®Google Scholar
• Kumar, V., S. Green, G. Stack, M. Berry, J.-R. Jin, and P. Chambon. 1987. Functional domains of the human estrogen receptor. Cell 51:941–951.
   PubMed Web of Science ®Google Scholar
• Lange, C. A., T. Shen, and K. B. Horwitz. 2000. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proc. Natl. Acad. Sci. USA 97:1032–1037.
   PubMed Web of Science ®Google Scholar
• LeGoff, P., M. M. Montano, D. J. Schodin, and B. S. Katzenellenbogen. 1994. Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. J. Biol. Chem. 269:4458–4466.
   PubMedGoogle Scholar
• Lin, H.-K., S. Altuwaijri, W.-J. Lin, P.-Y. Kan, L. L. Collins, and C. Chang. 2002. Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells. J. Biol. Chem. 277:36570–36576.
   PubMed Web of Science ®Google Scholar
• Lonard, D. M., Z. Nawaz, C. L. Smith, and B. W. O'Malley. 2000. The 26S proteasome is required for estrogen receptor-α and coactivator turnover and for efficient estrogen receptor-α transactivation. Mol. Cell 5:939–948.
   PubMed Web of Science ®Google Scholar
• Masuyama, H., and Y. Hiramatsu. 2004. Involvement of suppressor for Gal1 in ubiquitin/proteasome mediated degradation of estrogen receptor. J. Biol. Chem. 26:12020–12026.
   Google Scholar
• Masuyama, H., and P. N. MacDonald. 1998. Proteasome-mediated degradation of the vitamin D receptor (VDR) and a putative role for SUG1 interaction with the AF-2 domain of VDR. J. Cell. Biochem. 71:429–440.
   PubMed Web of Science ®Google Scholar
• Mètivier, R., G. Penot, M. R. Hübner, G. Reid, H. Brand, M. Koš, and F. Gannon. 2003. Estrogen receptor-α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115:751–763.
   PubMed Web of Science ®Google Scholar
• Mètivier, R., A. Stark, G. Flouriot, M. R. Hübner, H. Brand, G. Penot, D. Manu, S. Denger, G. Reid, M. Koš, R. B. Russell, O. Kah, F. Pakdel, and F. Gannon. 2002. A dynamic structural model for estrogen receptor-α activation by ligands, emphasizing the role of interactions between distant A and E domains. Mol. Cell 10:1019–1023.
   PubMed Web of Science ®Google Scholar
• Miyamoto, S., B. J. Seufzer, and S. Shumway. 1998. Novel IκBα proteolytic pathway in WEHI231 immature B cells. Mol. Cell. Biol. 18:19–29.
   PubMedGoogle Scholar
• Molinari, E., M. Gilman, and S. Natesan. 1999. Proteasome-mediated degradation of transcriptional activators correlates with activation domain potency in vivo. EMBO J. 18:6439–6447.
   PubMed Web of Science ®Google Scholar
• Muratani, M., and W. P. Tansey. 2003. How the ubiquitin-proteasome system controls transcription. Nat. Rev. 4:1–10.
   Google Scholar
• Nawaz, Z., D. M. Lonard, C. L. Smith, E. Lev-Lohman, S. Y. Tsai, M.-J. Tsai, and B. W. O'Malley. 1999. The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol. Cell. Biol. 19:1182–1189.
   PubMed Web of Science ®Google Scholar
• Nawaz, Z., D. M. Lonard, A. P. Dennis, C. L. Smith, and B. W. O'Malley. 1999. Proteasome-dependent degradation of the human estrogen receptor. Proc. Natl. Acad. Sci. USA 96:1858–1862.
   PubMed Web of Science ®Google Scholar
• Nomura, Y., T. Nagaya, Y. Hayashi, F. Kambe, and H. Seo. 1999. 9-cis-retinoic acid decreases the level of its cognate receptor, retinoic X receptor, through acceleration of the turnover. Biochem. Biophys. Res. Commun. 260:729–733.
   PubMedGoogle Scholar
• Osburn, D. L., G. Shao, H. M. Seidel, and I. G. Schulman. 2001. Ligand-dependent degradation of retinoid X receptors does not require transcriptional activity or coactivator interactions. Mol. Cell. Biol. 21:4909–4918.
   PubMed Web of Science ®Google Scholar
• Pickart, C. M. 2001. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70:503–533.
   PubMed Web of Science ®Google Scholar
• Preisler-Mashek, M. T., N. Solodin, B. L. Stark, M. K. Tyriver, and E. T. Alarid. 2002. Ligand-specific regulation of proteasome-mediated proteolysis of estrogen receptor-α. Am. J. Physiol. Endocrinol Metab. 282:E891–E898.
   PubMedGoogle Scholar
• Reid, G., M. R. Hubner, R. Metivier, B. Heike, S. Denger, D. Manu, J. Beaudouin, J. Ellenberg, and F. Gannon. 2003. Cyclic, proteasome-mediated turnover of unliganded and liganded ERα on responsive promoters is an integral feature of estrogen signaling. Mol. Cell 11:695–707.
   PubMed Web of Science ®Google Scholar
• Rubin, D. M., O. Coux, I. Wefes, C. Hengartner, R. A. Young, A. L. Goldberg, and D. Finley. 1996. Identification of the gal4 suppressor Sug1 as a subunit of the yeast 26S proteasome. Nature 379:655–657.
   PubMed Web of Science ®Google Scholar
• Salghetti, S. E., M. Muratani, H. Wijnen, B. Futcher, and W. P. Tansey. 2000. Functional overlap of sequences that activate transcription and signal ubiquitin-mediated proteolysis. Proc. Natl. Acad. Sci. USA 97:3118–3123.
   PubMed Web of Science ®Google Scholar
• Shang, Y., X. Hu, J. DiRenzo, M. A. Lazar, and M. Brown. 2000. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843–852.
   PubMed Web of Science ®Google Scholar
• Shao, W., E. K. Keeton, D. P. McDonnell, and M. Brown. 2004. Coactivator AIB1 links estrogen receptor transcriptional activity and stability. Proc. Natl. Acad. Sci. USA 101:11599–11604.
   PubMedGoogle Scholar
• Shull, J. D., J. H. Walent, and J. Gorski. 1987. Estradiol stimulates prolactin gene transcription in primary cultures of rat anterior pituitary cells. J. Steroid Biochem. 26:451–456.
   PubMedGoogle Scholar
• Soulez, M., and M. G. Parker. 2001. Identification of novel oestrogen receptor target genes in human ZR175-1 breast cancer cells by expression profiling. J. Mol. Endocrinol. 27:259–274.
   PubMedGoogle Scholar
• Stenoien, D. L., M. G. Mancini, K. Patel, E. A. Allegretto, C. L. Smith, and M. A. Mancini. 2000. Subnuclear trafficking of estrogen receptor-α and steroid receptor coactivator-1. Mol. Endocrinol. 14:518–534.
   PubMedGoogle Scholar
• Tateishi, Y., Y. Kawabe, T. Chiba, S. Murata, K. Ichikawa, A. Murayama, K. Tanaka, T. Baba, S. Kato, and J. Yanagisawa. 2004. Ligand-dependent switching of ubiquitin-proteasome pathways for estrogen receptor. EMBO J. 23:4813–4823.
   PubMed Web of Science ®Google Scholar
• Wallace, A. D., and J. A. Cidlowski. 2001. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. J. Biol. Chem. 276:42714–42721.
   PubMed Web of Science ®Google Scholar
• Watters, J. J., J. S. Campbell, J. J. Cunningham, E. G. Krebs, and D. M. Dorsa. 1997. Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. Endocrinology 138:4030–4033.
   PubMed Web of Science ®Google Scholar
• Whitesell, L., and P. Cook. 1996. Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells. Mol. Endocrinol. 10:705–712.
   PubMed Web of Science ®Google Scholar
• Wijayaratne, A. L., and D. P. McDonnell. 2001. The human estrogen receptor-α is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists and selective estrogen receptor modulators. J. Biol. Chem. 276:35684–35692.
   PubMed Web of Science ®Google Scholar
• Wormke, M., M. Stoner, B. Saville, K. Walker, M. Abdelrahim, R. Burghardt, and S. Safe. 2003. The aryl hydrocarbon receptor mediates degradation of estrogen receptor α through activation of proteasomes. Mol. Cell. Biol. 23:1843–1855.
   PubMed Web of Science ®Google Scholar
• Zhu, J., M. Gianni, E. Kopf, N. Honore, M. Chelbi-Alix, M. Koken, F. Quignon, C. Rochette-Egly, and H. de The. 1999. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor α (RARα) and oncogenic RARα fusion proteins. Proc. Natl. Acad. Sci. USA 96:14807–14812.
   PubMed Web of Science ®Google Scholar